מודרנה היא חברת ביוטכנולוגיה אמריקאית פורצת דרך, אשר חרטה על דגלה את החדשנות והקידמה בתחום הרפואה. החברה, שנוסדה בשנת 2010, מתמקדת בפיתוח חיסונים ותרופות המבוססים על טכנולוגיית mRNA (RNA שליח) – טכנולוגיה מהפכנית המאפשרת לגוף לייצר חלבונים טיפוליים בעצמו. גישה חדשנית זו פותחת פתח לטיפול במגוון רחב של מחלות, החל ממחלות זיהומיות ועד לסרטן ומחלות אוטואימוניות.
Comparison, examination, and analysis between investment houses
Leave your details, and an expert from our team will get back to you as soon as possible
* This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.
To read more about the full disclaimer, click here
- orshu
- •
- 9 Min Read
- •
- ago 2 minutes
Restaurant Stocks Under Pressure: Only McDonald’s and Shake Shack Buck the Trend
It’s been a turbulent week for restaurant stocks, with the sector broadly underperforming amid mounting macroeconomic pressures and shifting consumer
- ago 2 minutes
- •
- 9 Min Read
It’s been a turbulent week for restaurant stocks, with the sector broadly underperforming amid mounting macroeconomic pressures and shifting consumer

- orshu
- •
- 7 Min Read
- •
- ago 36 minutes
Foreign Ownership in U.S. Equities Hits Record High: Strategic Opportunity or Structural Risk?
As of mid-2025, foreign investors now hold 18% of U.S. corporate equities – an all-time high in recorded history. This
- ago 36 minutes
- •
- 7 Min Read
As of mid-2025, foreign investors now hold 18% of U.S. corporate equities – an all-time high in recorded history. This

- orshu
- •
- 8 Min Read
- •
- ago 53 minutes
Breaking Down the S&P 500 Rally: Sector-by-Sector Analysis of Earnings vs. Valuation Expansion
The 8.6% year-to-date gain in the S&P 500 during 2025 isn’t the result of a single factor—it’s a combination of moderate earnings
- ago 53 minutes
- •
- 8 Min Read
The 8.6% year-to-date gain in the S&P 500 during 2025 isn’t the result of a single factor—it’s a combination of moderate earnings

- orshu
- •
- 5 Min Read
- •
- ago 2 hours
Tesla and LG Energy Ink $4.3 Billion Battery Supply Deal: Will the Agreement Accelerate Energy Storage Solutions?
Tesla (NASDAQ:TSLA) and South Korean battery giant LG Energy Solution (KS:373220) have signed a significant contract worth $4.3 billion for the supply of lithium iron
- ago 2 hours
- •
- 5 Min Read
Tesla (NASDAQ:TSLA) and South Korean battery giant LG Energy Solution (KS:373220) have signed a significant contract worth $4.3 billion for the supply of lithium iron